Measuring Cell Viability: Methods and Applications

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to Cell Viability Measurement

What Is Cell Viability?

Cell viability is the quantification of the proportion of living, metabolically functional cells within a population. A viable cell is one that maintains an intact plasma membrane, possesses active metabolism, and retains the capacity to grow and divide under appropriate conditions. This definition is operational: viability is always measured through proxies—membrane integrity, enzymatic activity, or energy status—because no single universal marker defines "alive" at the cellular level.

It is critical to distinguish cell viability from two related but distinct concepts. Cell proliferation measures the increase in cell number over time, reflecting the balance between cell division and cell death. A population can have high viability but zero proliferation (e.g., contact-inhibited or senescent cells). Cytotoxicity refers to the ability of a substance to kill cells; it is the negative outcome that viability assays detect. When you treat cells with a drug and measure viability afterward, you are indirectly quantifying cytotoxicity. The relationship is straightforward: viability (%) = (live cells / total cells) × 100.

Why Measure Viability?

Viability measurement is foundational across biology and biotechnology. In drug development, viability assays screen compound libraries for anticancer activity or for unintended toxicity in normal cells. In Animal Cell Culture, viability determines when to passage cells, how many viable cells to seed, and whether a culture is healthy enough for experiments. In biomanufacturing, viability monitoring in a Mammalian Cell Culture Bioreactor predicts product yield, as dead cells release proteases that degrade recombinant proteins. In toxicology, viability assays assess environmental contaminants or cosmetic ingredients. In basic research, viability data validate gene-editing experiments, infection models, and metabolic studies.

The choice of assay matters because each method measures a different aspect of cellular health, and results can diverge depending on the cell type, the stressor applied, and the time point of measurement. Understanding the principles behind each method allows you to select the appropriate tool and interpret results correctly.

Principles of Viability Assays

All viability assays rely on one of three fundamental biological markers: membrane integrity, metabolic activity, or ATP content. Each marker reflects a different aspect of cellular health, and each has strengths and limitations.

Membrane Integrity as a Marker

The plasma membrane is a selective barrier that maintains intracellular homeostasis. When a cell dies—whether by necrosis, apoptosis, or other mechanisms—the membrane loses its integrity and becomes permeable to molecules that are normally excluded. Dyes such as trypan blue, propidium iodide (PI), and 7-aminoactinomycin D (7-AAD) exploit this loss of barrier function. These dyes cannot cross an intact membrane, but they readily enter dead or dying cells and bind to intracellular components (nucleic acids, proteins), producing a detectable signal.

Membrane integrity assays are simple, rapid, and inexpensive. Their main limitation is that they detect only the endpoint of cell death. A cell that has lost membrane integrity is dead, but a cell with an intact membrane is not necessarily viable—it could be metabolically compromised, apoptotic (with an intact membrane but fragmented DNA), or in a quiescent state.

Metabolic Activity and Redox State

Live cells continuously perform enzymatic reactions to generate energy and biosynthetic precursors. Many viability assays measure the activity of oxidoreductase enzymes in the mitochondria and cytoplasm. These enzymes transfer electrons from metabolic substrates (NADH, NADPH) to electron acceptors. Tetrazolium salts such as MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and resazurin are designed to intercept this electron flow. When reduced, MTT forms an insoluble purple formazan crystal, while resazurin forms the fluorescent compound resorufin.

The rate of dye reduction correlates with the metabolic capacity of the cell population. Metabolically active cells reduce more dye; dead cells reduce none. This approach is sensitive and can detect early stages of cell stress before membrane integrity is lost. However, metabolic activity varies with cell type, growth phase, and glucose availability, so results must be interpreted relative to appropriate controls.

ATP as an Energy Indicator

Adenosine triphosphate (ATP) is the universal energy currency of the cell. Viable cells maintain ATP concentrations within a narrow range (typically 1–10 mM intracellularly) through oxidative phosphorylation and glycolysis. When cells die, ATP is rapidly depleted because ATPases continue to hydrolyze it while synthesis stops. The half-life of ATP in dying cells is minutes, making ATP content a sensitive and early marker of cell death.

ATP is measured using the enzyme luciferase, which catalyzes the oxidation of luciferin in the presence of ATP and molecular oxygen, producing light. The amount of light emitted is directly proportional to ATP concentration. This assay is extremely sensitive—capable of detecting as few as 10–100 cells—and is compatible with high-throughput screening in 384- and 1536-well plates.

Direct Counting Methods

Trypan Blue Exclusion Test

The trypan blue exclusion test is the classic method for assessing cell viability by membrane integrity. Trypan blue is a diazo dye with a molecular weight of 961 Da. It carries a net negative charge and cannot cross intact plasma membranes. When a cell's membrane is compromised, the dye enters the cytoplasm and binds to intracellular proteins, staining the cell blue.

Protocol:

1. Prepare a cell suspension at a concentration between 1 × 10⁵ and 1 × 10⁶ cells/mL.
2. Mix 10 µL of cell suspension with 10 µL of 0.4% trypan blue solution (in phosphate-buffered saline, PBS).
3. Incubate at room temperature for 1–3 minutes. Do not exceed 5 minutes, as prolonged exposure is toxic to cells and can cause false positives.
4. Load 10 µL of the mixture into a hemocytometer chamber.
5. Count clear (viable) and blue (non-viable) cells under a light microscope at 100× magnification.

Calculation:

Viability (%) = (Number of clear cells / Total number of cells counted) × 100

A healthy culture should show >90% viability. Lower values indicate stress, contamination, or suboptimal culture conditions. The trypan blue method is inexpensive and requires no specialized equipment, but it is subjective, has limited throughput, and cannot distinguish between apoptotic and necrotic cells (both take up the dye once membrane integrity is lost).

Using a Hemocytometer

The hemocytometer is a thick glass slide with two counting chambers, each containing a grid of known dimensions. The central grid is 3 mm × 3 mm, divided into nine large squares of 1 mm × 1 mm. The depth of the chamber is 0.1 mm, so the volume above one large square is 0.1 µL (1 mm × 1 mm × 0.1 mm = 0.1 mm³ = 0.1 µL).

Counting procedure:

1. Clean the hemocytometer and coverslip with 70% ethanol and dry thoroughly.
2. Moisten the coverslip and press it over the counting chambers until Newton's rings (rainbow interference patterns) appear.
3. Pipette 10 µL of the trypan blue–cell mixture into the V-shaped groove at the edge of the chamber. Capillary action will draw the liquid under the coverslip.
4. Focus on the grid at 100× magnification. Count cells in the four corner squares (each 1 mm × 1 mm) of the central grid. Count at least 100 cells total for statistical reliability.
5. Count cells that touch the top and left borders of each square; do not count cells that touch the bottom and right borders. This prevents double-counting.

Cell concentration calculation:

Cells/mL = (Average number of cells per square) × (Dilution factor) × 10⁴

The factor 10⁴ converts the volume (0.1 µL per square) to 1 mL. For example, if you counted an average of 50 cells per square and diluted the sample 1:1 with trypan blue (dilution factor = 2), the concentration is 50 × 2 × 10⁴ = 1 × 10⁶ cells/mL.

Automated Cell Counters

Automated cell counters (e.g., Countess, Vi-CELL, NucleoCounter) use the same trypan blue exclusion principle but replace the human eye with digital image analysis. A camera captures images of the counting chamber, and software identifies cells by size and circularity, classifying them as viable (clear) or non-viable (blue). These instruments improve reproducibility, eliminate operator bias, and process samples in seconds. Many models also calculate cell size distributions and can flag debris or clumps. For Cell Passaging, automated counters are particularly valuable because they provide rapid, consistent viability data that inform split ratios and seeding densities.

Metabolic Assays: MTT, XTT, and Resazurin

MTT Assay

The MTT assay, first described by Mosmann in 1983, measures the reduction of yellow, water-soluble MTT to purple, insoluble formazan crystals. This reduction is primarily catalyzed by NAD(P)H-dependent oxidoreductases in the mitochondria, although cytosolic enzymes also contribute. The formazan crystals accumulate in the cell and must be solubilized before measurement.

Step-by-step protocol:

1. Seed cells in a 96-well plate at a density of 5 × 10³ to 1 × 10⁴ cells per well in 100 µL of culture medium. Allow cells to attach and recover for 24 hours.
2. Treat cells with test compounds for the desired exposure time (typically 24–72 hours).
3. Add 10 µL of MTT solution (5 mg/mL in PBS, filter-sterilized) to each well. Final MTT concentration is 0.5 mg/mL.
4. Incubate at 37 °C in a 5% CO₂ incubator for 2–4 hours. The incubation time depends on cell type and metabolic rate; check periodically for purple crystal formation.
5. Remove the medium carefully without disturbing the crystals. Add 100 µL of dimethyl sulfoxide (DMSO) to each well to dissolve the formazan.
6. Measure absorbance at 570 nm using a microplate reader. Use 630 nm as a reference wavelength to subtract background.
7. Calculate viability as a percentage of untreated control wells: Viability (%) = (Absorbance of treated well / Absorbance of control well) × 100.

The MTT assay is widely used because it is simple, inexpensive, and does not require specialized equipment beyond a plate reader. However, it has notable limitations. The formazan crystals must be solubilized, which adds a step and can introduce error if crystals are lost. The assay is endpoint-only; you cannot monitor viability over time in the same well. Some compounds, particularly antioxidants, can directly reduce MTT and produce false-positive results. For detailed troubleshooting, refer to Mtt Assay Cell Viability.

XTT and WST Assays

XTT (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) and WST (water-soluble tetrazolium) salts were developed to overcome the solubility problem of MTT. These tetrazolium compounds carry negatively charged sulfonate groups, making the reduced formazan water-soluble. No solubilization step is required; you can measure absorbance directly in the culture medium.

XTT requires an electron coupling reagent, such as phenazine methosulfate (PMS) at a final concentration of 0.15–0.3 mM, to facilitate electron transfer from NADH to the tetrazolium salt. WST-1 and WST-8 (the latter used in the CCK-8 kit) do not require a coupling agent because they are more efficiently reduced by cellular dehydrogenases. WST-8 is reduced to an orange formazan with absorbance at 450 nm.

The protocol is similar to MTT, but after incubation (1–4 hours), you measure absorbance directly at 450–490 nm (reference wavelength 650 nm). These assays are more amenable to kinetic studies because you can take repeated readings from the same well.

Resazurin Reduction (Alamar Blue)

Resazurin is a blue, non-fluorescent dye that is irreversibly reduced to pink, highly fluorescent resorufin by mitochondrial, microsomal, and cytosolic oxidoreductases. The assay is performed by adding resazurin (typically 10–50 µM final concentration) directly to the culture medium.

Protocol:

1. Prepare cells and treat as described for MTT.
2. Add resazurin solution (0.15 mg/mL in PBS) to each well at 10% of the well volume (e.g., 10 µL per 100 µL medium).
3. Incubate at 37 °C for 1–4 hours. The incubation time depends on cell density and metabolic activity.
4. Measure fluorescence with excitation at 530–560 nm and emission at 590 nm, or measure absorbance at 570 nm (reference 600 nm).
5. Calculate viability relative to untreated controls.

The resazurin assay is more sensitive than MTT, detects as few as 100 cells per well, and is non-toxic to cells at working concentrations. This allows you to add resazurin, measure fluorescence, and return the plate to the incubator for continued culture—enabling kinetic studies. However, resorufin can be further reduced to non-fluorescent hydroresorufin in some cell types, which can underestimate viability. The assay is also affected by serum components and phenol red, so proper blanks are essential.

ATP-Based Viability Assays

Luciferase Reaction

ATP-based viability assays use the firefly luciferase enzyme to generate a bioluminescent signal proportional to ATP concentration. The reaction is:

ATP + D-luciferin + O₂ → oxyluciferin + AMP + PPi + CO₂ + light (λmax = 560 nm)

The enzyme is highly specific for ATP, and the reaction produces a stable "glow" signal that persists for 30 minutes to several hours, depending on the formulation. Commercial kits (e.g., CellTiter-Glo, ATPlite) include a detergent-based lysis buffer that simultaneously lyses cells, inactivates endogenous ATPases, and provides the luciferase and luciferin in a stabilized form.

Protocol:

1. Culture cells in a white-walled, clear-bottom 96-well plate (white walls reflect light and prevent well-to-well crosstalk).
2. Remove the plate from the incubator and allow it to equilibrate to room temperature for 10 minutes.
3. Add an equal volume of ATP assay reagent to the culture medium (e.g., 100 µL reagent to 100 µL medium).
4. Mix on an orbital shaker for 2 minutes to induce lysis.
5. Incubate at room temperature for 10 minutes to stabilize the signal.
6. Measure luminescence using a plate reader with an integration time of 0.25–1 second per well.

The luminescence signal is directly proportional to the number of viable cells. To calculate viability, compare treated wells to untreated controls: Viability (%) = (RLU treated / RLU control) × 100, where RLU is relative light units.

Advantages and Limitations

ATP assays are the most sensitive viability methods available, detecting as few as 10 cells per well. They have an excellent linear dynamic range (typically 3–4 orders of magnitude), making them ideal for high-throughput screening where cell numbers vary widely. The assay is homogeneous—no washing, medium removal, or solubilization steps—which reduces variability and makes it compatible with automation.

The main limitation is that ATP levels reflect not only cell number but also metabolic state. Cells that are stressed but alive may have reduced ATP, leading to an overestimation of cell death. Conversely, cells that are actively proliferating have higher ATP content per cell, which can mask moderate toxicity. The assay is also an endpoint measurement; you cannot monitor the same well over time. Additionally, the luciferase reaction is inhibited by some compounds, particularly those that are strongly reducing or that quench light (e.g., phenol red at high concentrations, some metal ions).

Fluorescent and Flow Cytometry Methods

Live/Dead Staining

Fluorescent viability dyes offer the advantage of multiplexing—you can simultaneously label live and dead cells with different fluorophores and analyze them by microscopy or flow cytometry.

Calcein AM is a non-fluorescent, membrane-permeable esterase substrate. Once inside a viable cell, intracellular esterases cleave the acetoxymethyl (AM) ester groups, producing calcein, a green-fluorescent (excitation 495 nm, emission 515 nm) molecule that is retained in the cytoplasm because it is now charged and cannot cross the membrane. Dead cells lack esterase activity and do not fluoresce.

Propidium iodide (PI) is a red-fluorescent nucleic acid stain (excitation 535 nm, emission 617 nm) that is excluded by intact membranes. It intercalates into double-stranded DNA and RNA. When used together with calcein AM, live cells appear green and dead cells appear red.

7-AAD (7-aminoactinomycin D) is similar to PI but has a larger molecular weight (1,270 Da vs. 668 Da for PI) and a longer emission wavelength (647 nm). Its larger size means it is excluded from cells with intact membranes even more effectively than PI, reducing false positives from cells that are slightly compromised. 7-AAD is preferred for multicolor flow cytometry because its emission spectrum overlaps less with other fluorophores.

Protocol for live/dead staining:

1. Prepare a working solution of 2 µM calcein AM and 4 µM PI in PBS or serum-free medium.
2. Remove culture medium and wash cells once with PBS.
3. Add the staining solution and incubate at 37 °C for 15–30 minutes.
4. Wash cells with PBS and visualize by fluorescence microscopy or analyze by flow cytometry.

Flow Cytometry Analysis

Flow cytometry quantifies the fluorescence of individual cells as they pass through a laser beam, allowing you to determine the percentage of viable, apoptotic, and necrotic cells in a population. The instrument measures forward scatter (FSC, related to cell size) and side scatter (SSC, related to granularity), along with fluorescence in multiple channels.

For viability analysis, cells are stained with a membrane-impermeant dye (PI or 7-AAD) and analyzed. Viable cells are negative for the dye; dead cells are positive. When combined with Annexin V staining—which binds to phosphatidylserine externalized on the surface of apoptotic cells—you can distinguish four populations:

• Live cells: Annexin V-negative, PI-negative
• Early apoptotic: Annexin V-positive, PI-negative
• Late apoptotic/necrotic: Annexin V-positive, PI-positive
• Necrotic: Annexin V-negative, PI-positive

Flow cytometry is quantitative, objective, and can analyze thousands of cells per second. It is the method of choice when you need to distinguish cell death modes or when your cell population is heterogeneous (e.g., mixed cell types in a co-culture). The main drawbacks are the cost of the instrument, the need for trained operators, and the requirement that cells be in suspension (adherent cells must be trypsinized, which can itself damage membranes and create artifacts).

Choosing the Right Assay

Factors to Consider

Selecting a viability assay requires balancing several factors:

Cell type: Adherent cells are compatible with all assays, but suspension cells are easier to count by flow cytometry. Primary cells, which are often slow-growing and sensitive, may be better assessed with non-toxic assays like resazurin that allow continued culture. For Primary Cell Culture Guidelines, minimize manipulation; a homogeneous ATP assay requires only one reagent addition.

Throughput: If you are screening thousands of compounds, you need a homogeneous, one-step assay compatible with 384-well plates. ATP-based assays and resazurin are ideal. Trypan blue counting is impractical at this scale.

Sensitivity: ATP assays detect the fewest cells (10–100). MTT requires at least 1,000 cells per well. Fluorescent assays fall in between.

Kinetic vs. endpoint: Resazurin is non-toxic and can be measured repeatedly. MTT and ATP assays are endpoint-only.

Interference: Test compounds may interfere with the assay. Compounds with reducing activity (e.g., ascorbic acid, some polyphenols) directly reduce tetrazolium salts, causing false positives. Compounds that quench fluorescence or absorb at the assay wavelength will distort results. Always run a cell-free control with the test compound to check for interference.

Cost and equipment: Trypan blue counting requires only a microscope. MTT requires a plate reader with absorbance capability. ATP assays require a luminometer. Flow cytometry requires a cytometer.

Comparison of Common Assays

Common Pitfalls and Troubleshooting

Pitfall: Overly High Cell Density

Seeding too many cells leads to rapid nutrient depletion, acidification of the medium (indicated by phenol red turning yellow), and contact inhibition. These conditions reduce metabolic activity per cell, causing metabolic assays to underestimate viability. Conversely, in ATP assays, high cell density can exceed the linear range of the luciferase reaction, producing a signal that plateaus and masks differences between treated and control groups.

Solution: Determine the optimal seeding density for each cell type by performing a growth curve. For 96-well plates, typical seeding densities range from 5 × 10³ to 2 × 10⁴ cells per well for adherent cell lines. Ensure that control cells do not exceed 80–90% confluency at the time of assay.

Pitfall: Interference from Test Compounds

Many compounds interfere with viability assays. Reducing agents (e.g., dithiothreitol, β-mercaptoethanol, glutathione) directly reduce MTT, XTT, and resazurin, generating signal without cells. Compounds with intrinsic absorbance or fluorescence at the assay wavelengths (e.g., doxorubicin absorbs at 480 nm, interfering with WST-1 readings) produce false signals. Some compounds quench luciferase luminescence.

Solution: Always include a cell-free control containing the test compound at the same concentration used in the experiment. If the compound produces signal in the absence of cells, switch to an assay based on a different principle (e.g., from MTT to ATP). For fluorescent assays, check the compound's excitation and emission spectra for overlap.

Pitfall: Ignoring Background Signal

Culture medium, serum, and phenol red contribute background absorbance and fluorescence. In MTT assays, residual medium can increase absorbance readings. In ATP assays, the lysis buffer itself produces a low level of luminescence. In resazurin assays, serum can slowly reduce resazurin even without cells.

Solution: Include blank wells containing medium and reagents but no cells. Subtract the average blank value from all readings. For fluorescent assays, use a reference wavelength or measure fluorescence before adding the reagent to establish baseline.

Pitfall: Incorrect Incubation Time

Too-short incubation with MTT or resazurin produces weak signal with poor signal-to-noise ratio. Too-long incubation causes the dye to become toxic (MTT is toxic after 4 hours) or leads to over-reduction (resazurin to hydroresorufin), which decreases fluorescence. The optimal incubation time varies with cell type and density.

Solution: Perform a time-course experiment for each new cell type. Read the plate at 1, 2, 3, and 4 hours to identify the linear range of dye reduction. Choose the earliest time point that gives a signal at least 5-fold above background.

Pitfall: Cell Loss During Washing

Metabolic assays on adherent cells require removal of medium and washing steps. If cells are weakly adherent (e.g., some primary cells or cells treated with compounds that disrupt adhesion), washing can remove cells and underestimate viability. Conversely, if cells are over-confluent, they may detach in sheets.

Solution: Use gentle pipetting and pre-warm all buffers to 37 °C. For weakly adherent cells, consider a homogeneous assay (ATP or resazurin) that does not require washing. Alternatively, fix cells with 4% paraformaldehyde before staining, but note that fixation kills cells and is only appropriate for endpoint analysis.

Pitfall: Misinterpreting Metabolic Assays as Cell Counts

Metabolic assays measure total enzymatic activity, which depends on both cell number and per-cell metabolic rate. A compound that inhibits metabolism without killing cells (e.g., a glycolysis inhibitor like 2-deoxyglucose) will reduce MTT signal and appear cytotoxic, even though cells remain viable and can recover. Conversely, cells stimulated to proliferate (e.g., by growth factors) will show increased signal that may mask a mild cytotoxic effect.

Solution: Confirm metabolic assay results with an independent method based on a different principle. For example, if MTT shows a 50% reduction in viability, verify with trypan blue exclusion or an ATP assay. If the results diverge, the compound may be affecting metabolism rather than cell survival.

Practical Summary and Best Practices

Step-by-Step Workflow

1. Define your question. Are you measuring acute toxicity (hours), chronic effects (days), or screening thousands of compounds? This determines the assay format.
2. Select the assay. Match the assay to your cell type, throughput needs, and available equipment. Use the comparison table above as a guide.
3. Optimize cell density. Perform a seeding density curve to identify the range where the assay signal is linear with cell number.
4. Include all controls. At minimum: untreated cells (negative control), cells treated with a known cytotoxic agent (positive control, e.g., 10% DMSO or 100 µM hydrogen peroxide), and cell-free blanks with and without test compound.
5. Run a pilot experiment. Test your assay with a known positive control to validate that it detects cell death in your system.
6. Perform the assay. Follow the protocol precisely, noting incubation times and temperatures.
7. Analyze data. Subtract blanks, calculate viability as a percentage of control, and perform appropriate statistical tests (e.g., t-test for two groups, ANOVA for multiple groups).
8. Validate with a second method. Confirm key findings with an independent assay based on a different principle.

Controls and Validation

The most common error in viability measurement is the absence of proper controls. The negative control (untreated cells) defines 100% viability. The positive control (cells treated with a known lethal agent) confirms that the assay can detect cell death. Without these, you cannot interpret experimental results.

Validation is equally important. When you use a new cell type, new reagent batch, or new compound, verify that the assay performs as expected. For metabolic assays, confirm that the signal is proportional to cell number by counting cells and plotting signal vs. cell count. For ATP assays, verify the linear range by preparing a serial dilution of cells. This validation takes time but prevents costly misinterpretations.

For Primary and Secondary Cell Culture, note that primary cells are more sensitive to manipulation and may have lower baseline viability than immortalized lines. Adjust your protocols accordingly—use gentler dissociation, shorter incubation times, and lower dye concentrations.

Frequently Asked Questions

How do you measure cell viability?

Cell viability is measured by detecting a biological marker that distinguishes live from dead cells. The most common approaches are: (1) membrane integrity, using dyes like trypan blue or propidium iodide that enter only cells with damaged membranes; (2) metabolic activity, using tetrazolium salts (MTT, XTT) or resazurin that are reduced by enzymes in live cells; and (3) ATP content, measured by the luciferase reaction. Each method has advantages and limitations, and the choice depends on cell type, throughput, and available equipment. To calculate viability, divide the number of live cells by the total number of cells and multiply by 100. See Calculate Cell Viability for worked examples.

What is the most accurate cell viability assay?

There is no single "most accurate" assay because accuracy depends on context. ATP-based assays are the most sensitive and have the widest linear range, detecting as few as 10 cells per well. However, they measure metabolic state, not just cell survival. Flow cytometry with live/dead staining provides single-cell resolution and can distinguish apoptosis from necrosis, but requires cells in suspension and expensive equipment. For most applications, the most accurate approach is to use two independent assays based on different principles—for example, an ATP assay (energy status) combined with trypan blue exclusion (membrane integrity). If both agree, you can be confident in the result.

What is the difference between cell viability and cell proliferation?

Cell viability is the proportion of live cells in a population at a given moment. Cell proliferation is the increase in cell number over time, resulting from cell division. A culture can have 100% viability but zero proliferation (e.g., contact-inhibited cells). Conversely, a culture can have declining viability but still increase in total cell number if proliferation outpaces death. Viability assays measure a snapshot; proliferation assays (e.g., cell counting over time, BrdU incorporation, or CFSE dilution) measure a rate. Both are often needed to fully understand the effect of a treatment.

Why is trypan blue used for cell counting?

Trypan blue is used because it is a negatively charged dye that cannot cross intact plasma membranes. Live cells exclude the dye and appear clear under a light microscope. Dead cells have compromised membranes, allowing the dye to enter and bind to intracellular proteins, staining them blue. This provides a rapid, inexpensive, and direct visual distinction between live and dead cells. The method requires only a hemocytometer and a microscope, making it accessible to any laboratory. Its limitations are subjectivity, low throughput, and the inability to detect early apoptosis (cells that are dying but still have intact membranes).

How does the MTT assay work?

The MTT assay measures the reduction of yellow, water-soluble MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to purple, insoluble formazan crystals. This reduction is catalyzed by NAD(P)H-dependent oxidoreductase enzymes in the mitochondria and cytoplasm of metabolically active cells. The formazan crystals are then solubilized in DMSO or isopropanol, and the absorbance is measured at 570 nm. The absorbance is proportional to the number of metabolically active cells. Dead cells lack the enzymatic activity to reduce MTT and produce no signal. The assay is simple, inexpensive, and widely used, but it is an endpoint assay and can be affected by compounds that directly reduce MTT.

Can I use flow cytometry to measure cell viability?

Yes. Flow cytometry is a powerful method for measuring cell viability because it analyzes individual cells, providing both the percentage of viable cells and information about cell size, granularity, and multiple fluorescent markers simultaneously. The most common approach is to stain cells with a membrane-impermeant dye like propidium iodide or 7-AAD, which fluoresces only in dead cells. You can combine this with Annexin V staining to distinguish apoptosis from necrosis. Flow cytometry is quantitative, objective, and can analyze thousands of cells per second, making it ideal for heterogeneous populations. The main requirements are access to a cytometer and the ability to prepare a single-cell suspension.

What are common mistakes when measuring cell viability?

Common mistakes include: (1) seeding too many cells, which causes nutrient depletion and reduces metabolic activity per cell; (2) using incorrect incubation times, leading to weak signal or dye toxicity; (3) failing to include proper controls, especially cell-free blanks and positive controls; (4) ignoring interference from test compounds that reduce tetrazolium dyes or quench fluorescence; (5) washing away weakly adherent cells during the assay; and (6) misinterpreting metabolic assays as direct cell counts, since metabolic activity varies with cell state. The best defense is to validate your assay with a known positive control and confirm key results with a second, independent method.

Key Takeaways

• Cell viability measures the proportion of living cells in a population and is distinct from proliferation (rate of cell division) and cytotoxicity (the ability to kill cells).
• All viability assays rely on one of three biological markers: membrane integrity, metabolic activity, or ATP content.
• Trypan blue exclusion is the simplest and cheapest method but is subjective and endpoint-only; it is best for routine culture monitoring.
• Tetrazolium-based assays (MTT, XTT, WST) and resazurin measure metabolic activity and are suitable for 96-well plate formats, but they can be affected by compounds that directly reduce the dyes.
• ATP-based luciferase assays are the most sensitive and have the widest linear range, making them ideal for high-throughput screening.
• Flow cytometry with live/dead dyes provides single-cell resolution and can distinguish apoptosis from necrosis, but requires specialized equipment.
• Always include negative controls (untreated cells), positive controls (known cytotoxic agent), and cell-free blanks, and validate key findings with a second assay based on a different principle.

Further Reading

• Markossian S et al. Cell Viability Assays. 2004. PubMed 23805433
• Stoddart MJ. Cell viability assays: introduction. Methods in molecular biology (Clifton, N.J.). 2011. PubMed 21468961
• Lomakina GY, Modestova YA, Ugarova NN. Bioluminescence assay for cell viability. Biochemistry. Biokhimiia. 2015. PubMed 26531016
• Kumar P, Nagarajan A, Uchil PD. Analysis of Cell Viability by the Lactate Dehydrogenase Assay. Cold Spring Harbor protocols. 2018. PubMed 29858337
• Zhong J et al. Multi-frequency single cell electrical impedance measurement for label-free cell viability analysis. The Analyst. 2021. PubMed 33619511
• Chen A et al. Effects of diluents on cell culture viability measured by automated cell counter. PloS one. 2017. PubMed 28264018

Related Clinical & Scientific Guides

• MAPK Pathway: Mechanism, Function, and Clinical Relevance
• Mammalian Cell Culture Bioreactors: A Practical Guide
• Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks